Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer

Authors

Thomas Regenbogen, Washington University School of Medicine in St. Louis
Ling Chen, Washington University School of Medicine in St. Louis
Kathryn Trinkaus, Washington University School of Medicine in St. Louis
Andrea Wang-Gillam, Washington University School of Medicine in St. Louis
Benjamin R. Tan, Washington University School of Medicine in St. Louis
Manik Amin, Washington University School of Medicine in St. Louis
Katrina S. Pedersen, Washington University School of Medicine in St. Louis
Haeseong Park, Washington University School of Medicine in St. Louis
Rama Suresh, Washington University School of Medicine in St. Louis
Kian-Huat Lim, Washington University School of Medicine in St. Louis
Emily Ratchford, Washington University School of Medicine in St. Louis
Amberly Brown, Washington University School of Medicine in St. Louis
A Craig Lockhart, University of Miami

Journal

Journal of Gastrointestinal Oncology

Publication Date

12-1-2017

Volume

8

Issue

6

First Page

985

Last Page

989

Document Type

Open Access Publication

DOI

10.21037/jgo.2017.08.16

Rights and Permissions

Regenbogen T, Chen L, Trinkaus K, Wang-Gillam A, Tan BR, Amin M, Pedersen KS, Park H, Suresh R, Lim KH, Ratchford E, Brown A, Lockhart AC. Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer. J Gastrointest Oncol 2017;8(6):985-989. doi: 10.21037/jgo.2017.08.16

Recommended Citation

Regenbogen, Thomas; Chen, Ling; Trinkaus, Kathryn; Wang-Gillam, Andrea; Tan, Benjamin R.; Amin, Manik; Pedersen, Katrina S.; Park, Haeseong; Suresh, Rama; Lim, Kian-Huat; Ratchford, Emily; Brown, Amberly; and Lockhart, A Craig, "Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer." Journal of Gastrointestinal Oncology. 8, 6. 985 - 989. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/9925